Skip to playerSkip to main contentSkip to footer
  • 11 years ago
In the immediate aftermath of the Obamacare rollout, pharma and healthcare M&A fell. Now, however, it's back up, on deals like Monday morning's Covidien - Medtronic announcement, a merger valued at $43 billion. While some deals in the healthcare ind

Recommended